MedCity News October 18, 2019
Over the last few years, we’ve seen medtech investing soar to new heights. In 2017, venture capitalists reportedly poured $9 billion into the space, a 60 percent increase from the year prior. While more money is being allocated to innovation in this sector, there are still very few companies who have discovered the secret for delivering technologies that truly transform healthcare.
We are repeatedly seeing investments that make only incremental advancements in the standard of care that have a hard time successfully impacting patients’ wellbeing. These innovations are also struggling to achieve successful exits for investors. The reason for these failures is simple: they don’t go far enough in improving patient care and reducing costs. They are a small step...